Top compounds associated with response to MED26


Feature Type Standardized
Nominal ANOVA
mRNA silmitasertib CTRPv2 pan-cancer AAC -0.055 0.2
mRNA MI-2 CTRPv2 pan-cancer AAC 0.075 0.2
mRNA Crizotinib CTRPv2 pan-cancer AAC -0.046 0.2
mRNA RO4929097 CTRPv2 pan-cancer AAC 0.075 0.2
mRNA lapatinib CTRPv2 pan-cancer AAC -0.051 0.2
mRNA alisertib:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.049 0.2
mRNA BRD-K70511574 CTRPv2 pan-cancer AAC 0.045 0.2
mRNA navitoclax:PLX-4032 (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.048 0.2
mRNA neratinib CTRPv2 pan-cancer AAC -0.049 0.3
mRNA BIX-01294 CTRPv2 pan-cancer AAC 0.047 0.3
Download CSV